
|Articles|August 1, 2008
The American Journal of Managed Care
- August 2008
- Volume 14
- Issue 8
Participant Disclosure (Am J Manag Care. 2008;14[suppl 8]:S241-S268)
Advertisement
Our July 2008 supplement on Biologics and Benefit Design, funded by Amgen Inc, (Am J Manag Care. 2008;14[suppl 8]:S241-S268), included an error of omission on the Participant Disclosures page.
The following disclosures for Robert Berglund should have been noted on S244:
Robert Berglund
Honoraria, Amgen Inc
Articles in this issue
almost 18 years ago
A Meta-analysis Update: Percutaneous Coronary Interventionsalmost 18 years ago
Managed Care Enrollment and Chronically Disabled Women With Breast Canceralmost 18 years ago
Medicare HMO Impact on Utilization at the End of Lifealmost 18 years ago
Flunking Asthma? When HEDIS Takes the ACTAdvertisement
Advertisement
Advertisement
Trending on AJMC
1
New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment
2
Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis
3
JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain
4
Biologics Appear Renal-Safe in Psoriasis, IL-17 Agents Show Kidney Promise
5



